These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 28948234)

  • 1. Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
    Patocskai B; Yoon N; Antzelevitch C
    JACC Clin Electrophysiol; 2017 Apr; 3(4):353-363. PubMed ID: 28948234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome.
    Szél T; Antzelevitch C
    J Am Coll Cardiol; 2014 May; 63(19):2037-45. PubMed ID: 24657694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial Substrate as a Target for Radiofrequency Ablation in an Experimental Model of Early Repolarization Syndrome.
    Yoon N; Patocskai B; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2018 Sep; 11(9):e006511. PubMed ID: 30354293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
    Di Diego JM; Patocskai B; Barajas-Martinez H; Borbáth V; Ackerman MJ; Burashnikov A; Clatot J; Li GR; Robinson VM; Hu D; Antzelevitch C
    PLoS One; 2020; 15(11):e0242747. PubMed ID: 33232375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome.
    Szél T; Koncz I; Antzelevitch C
    Heart Rhythm; 2013 Nov; 10(11):1720-7. PubMed ID: 23911896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
    Patocskai B; Barajas-Martinez H; Hu D; Gurabi Z; Koncz I; Antzelevitch C
    Heart Rhythm; 2016 Jun; 13(6):1326-34. PubMed ID: 26820510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
    Brugada J; Pappone C; Berruezo A; Vicedomini G; Manguso F; Ciconte G; Giannelli L; Santinelli V
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1373-81. PubMed ID: 26291334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.
    Koncz I; Gurabi Z; Patocskai B; Panama BK; Szél T; Hu D; Barajas-Martínez H; Antzelevitch C
    J Mol Cell Cardiol; 2014 Mar; 68():20-8. PubMed ID: 24378566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
    Minoura Y; Di Diego JM; Barajas-Martínez H; Zygmunt AC; Hu D; Sicouri S; Antzelevitch C
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):423-32. PubMed ID: 22034916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Non-Invasive Epicardial and Endocardial Mapping in Patients With Brugada Syndrome: New Insights Into Arrhythmia Mechanisms.
    Rudic B; Chaykovskaya M; Tsyganov A; Kalinin V; Tülümen E; Papavassiliu T; Dösch C; Liebe V; Kuschyk J; Röger S; El-Battrawy I; Akin I; Yakovleva M; Zaklyazminskaya E; Shestak A; Kim S; Chmelevsky M; Borggrefe M
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST-Segment Elevation and Fractionated Electrograms in Brugada Syndrome Patients Arise From the Same Structurally Abnormal Subepicardial RVOT Area but Have a Different Mechanism.
    Ten Sande JN; Coronel R; Conrath CE; Driessen AH; de Groot JR; Tan HL; Nademanee K; Wilde AA; de Bakker JM; van Dessel PF
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1382-92. PubMed ID: 26480928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome.
    Zhang P; Tung R; Zhang Z; Sheng X; Liu Q; Jiang R; Sun Y; Chen S; Yu L; Ye Y; Fu G; Shivkumar K; Jiang C
    Heart Rhythm; 2016 Nov; 13(11):2151-2158. PubMed ID: 27453126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome.
    Fish JM; Welchons DR; Kim YS; Lee SH; Ho WK; Antzelevitch C
    Circulation; 2006 Mar; 113(11):1393-400. PubMed ID: 16534004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
    Morita H; Zipes DP; Morita ST; Wu J
    Heart Rhythm; 2007 Jan; 4(1):66-74. PubMed ID: 17198993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
    Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K
    J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisite conduction block in the epicardial substrate of Brugada syndrome.
    Haïssaguerre M; Nademanee K; Sacher F; Cheniti G; Hocini M; Surget E; Dubois R; Vigmond E; Bernus O
    Heart Rhythm; 2022 Mar; 19(3):417-426. PubMed ID: 34737095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Modulation of Right Ventricular Endocardial-Epicardial Gradients in Brugada Syndrome.
    Bhar-Amato J; Finlay M; Santos D; Orini M; Chaubey S; Vyas V; Taggart P; Grace AA; Huang CL; Ben Simon R; Tinker A; Lambiase PD
    Circ Arrhythm Electrophysiol; 2018 Sep; 11(9):e006330. PubMed ID: 30354290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.
    Nademanee K; Raju H; de Noronha SV; Papadakis M; Robinson L; Rothery S; Makita N; Kowase S; Boonmee N; Vitayakritsirikul V; Ratanarapee S; Sharma S; van der Wal AC; Christiansen M; Tan HL; Wilde AA; Nogami A; Sheppard MN; Veerakul G; Behr ER
    J Am Coll Cardiol; 2015 Nov; 66(18):1976-1986. PubMed ID: 26516000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.